Group Acceptance and Commitment Therapy for Japanese patients with Depressive or Anxiety symptoms: A Pilot Study
Not Applicable
Recruiting
- Conditions
- Subjective depressive and/or anxiety symptoms
- Registration Number
- JPRN-UMIN000029598
- Lead Sponsor
- Tokyo Musashino Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Manic state or psychotic symptoms (2) Diagnosis of schizophrenia (3) Diagnosis of dementia (4) Currently receiving any other structured psychotherapy during the intervention (5) Other relevant reason decided by the investigators
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Beck Depression Inventory-2(pre-treatment, 8 week,12 week and 20 week.)
- Secondary Outcome Measures
Name Time Method (1) Diagnoses assessed by the M.I.N.I. (2) State-Trait Anxiety Inventory (3) 36-item Short Form Health Survey (4) Mindful Attention Awareness Scale (5) Acceptance and Action Questionnaire-2 (6) Satisfaction (7) Dropout rate (8) Adverse evnents (9) The usuability of the program evaluated by CP,OT,PSW (1) to (4) are evaluated at pre-treatment,8week and 12week. (5) is conducted at pre-treatment,3week,5week,7week,8week and 12week. (6) is conducted at every session.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the molecular mechanisms of ACT in treating depressive and anxiety symptoms in Japanese populations?
How does group ACT compare to standard-of-care therapies for depressive and anxiety symptoms in Japan?
Are there specific biomarkers that predict response to group ACT in patients with depressive or anxiety disorders?
What adverse events are associated with group ACT for depressive and anxiety symptoms and how are they managed?
What combination approaches or alternative therapies are being explored alongside ACT for treating depressive and anxiety symptoms in Japan?